22

th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …
Page 2: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

e are very proud to host our 74th meeting of the Canadian Society of Allergy and Clinical Immunology. This year brings together an outstanding faculty of

Canadian and international speakers who will share their expertise and insights as they cover the wide spectrum of clinical and basic sciences. As the primary Canadian gathering for the allergy community, it will provide an excellent opportunity for specialists and researchers in the field of allergy, asthma, and clinical immunology as well as allied health professionals from Canada and around the world to meet and share their knowledge in an atmosphere conducive to medical, scientific and social interaction. Have a great meeting!

Dr. Harold Kim Dr. David Fischer CSACI President 2019 Program Chair

W

Page 3: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

2019 ANNUAL SCIENTIFIC MEETING PLANNING COMMITTEE Dr. Harold Kim, CSACI President Dr. David Fischer, 2019 ASM Chair, CPD Committee Dr. Tim Vander Leek, CSACI Vice President Dr. Anne Ellis, CSACI Treasurer, FIT Bowl Chair Dr. Lori Connors, CPD Committee Chair Dr. Philippe Bégin, 2019 Program Committee Dr. Jean-Nicholas Boursiquot, 2019 Program Committee Dr. Scott Cameron, 2019 Program Committee, CPD Com. Dr. Edmond Chan, CSACI Board Dr. Victoria Cook, 2019 Program Committee, CPD Com. Dr. Ana-Maria Copaescu, FIT Representative Dr. Charles Frankish, 2019 Program Committee, CPD Com. Dr. Kyla Hildebrand, CSACI Board Ms. Sara Johnson, Allied Health Section Co-Advisor Dr. Sandy Kapur, 2019 Program Committee Dr. Elana Lavine, Pediatric Section Advisor Dr. Doug Mack, CSACI Board Dr. Christine McCusker, CSACI Board Dr. Luis Murguia, Immunology Section Advisor Dr. Andy O’Keefe, Asthma Section Advisor Dr. Jackie Quirt, Rhino-sinusitis Section Advisor Dr. Elinor Simons, Abstract Co-Chair Dr. Lianne Soller, Allied Health Section Co-Advisor Dr. Julia Upton, Anaphylaxis and Food Allergy Section Advisor Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi Campbell, Manager

PROGRAM OBJECTIVES The CSACI Annual Scientific Meeting’s main objective is to provide current information about the diagnosis, treatment and management for conditions related to allergy, asthma and immunology. This meeting is a setting for interdisciplinary exchange among professionals and provides an excellent opportunity for participants to interact with colleagues and experts in the field. By participating in this conference, attendees can expect to evaluate new trends, techniques, therapies and diagnostic procedures in allergy, asthma and immunology.

EVALUATIONS Delegates can provide feedback on Annual Meeting Sessions they attend by using the Annual Meeting app or by visiting the CSACI website.

WHY YOU SHOULD ATTEND! As the premier meeting of the allergy, asthma and immunology community, this conference provides several unique and engaging educational opportunities for the participant – you can:

• Interact with an impressive faculty of Canadian and international speakers;

• Network with colleagues across settings and disciplines;

• Translate scientific discoveries into your practice;

• Learn about policy issues that directly affect you;

• Raise questions, debate the issues, plan follow-up studies, and discuss results;

• Discuss your own research and observations;

• Meet with poster presenters to learn about their research objectives; and

• Visit a number of exhibit booths featuring products and services specifically designed for professionals in allergy, asthma and immunology.

TARGET AUDIENCE The CSACI Annual Scientific meeting is intended for clinicians, researchers, trainees/students, and allied health professionals involved in research, treatment and management of diseases in allergy, asthma and immunology.

CSACI Mission:

The Canadian Society of Allergy & Clinical Immunology advances allergy, asthma, and

immunology knowledge to optimize patient care across Canada.

CSACI Vision:

The leading expertise for care of people with allergic and immunologic disease. Striving for prevention and cure.

Page 4: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

ANNUAL GENERAL MEETING All CSACI members are invited to attend the CSACI and CAAIF AGMs Friday, October 25 from 1055-1200

Participants will be eligible to win a prize!

ACCREDITATION - (Section 1 & Section 3)

This event is pending an accredited group learning activity (Section 1 & Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. Please refer to the final program for accredited sessions. AMA PRA Category 1 Credit™ Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credits to AMA credits can be found at: www.ama-assn.org/go/internationalcme. CERTIFICATE OF ATTANDANCE All participating delegates will receive an email containing their “Certificate of Attendance” following the meeting.

PROGRAM CHANGES AND CANCELLATIONS Please note: The CSACI reserves the right to substitute faculty or to cancel or reschedule sessions because of low enrollment or other unforeseen circumstances.

DISCLOSURE Faculty and Moderator Disclosure: Current CME guidelines state that participants should be aware of any affiliation or financial interest that could affect the speaker’s presentation(s). Faculty and moderators have completed conflict of interest declarations and those potential conflicts will be listed in the announced at the beginning of each session. The intent of this disclosure requirement is not to prevent a speaker with a conflict of interest from making a presentation but to make known the relationship, in advance, to the audience. It is intended that any conflict be openly identified so that with full disclosure of the facts, attendees may form their own judgments about the presentation. In addition, all members of the annual scientific program committee have also completed their declaration and have announced at each teleconference or meeting any financial interest in commercial organizations that may have a direct or indirect interest in the subject matter of his/her presentation. A “financial interest” may include, but is not limited to, being a direct shareholder in the organization; being on retainer with the organization; or having research or honoraria paid by the organization. An “affiliation” may be holding a position on an advisory committee or some other role of benefit to a sponsoring organization.

DISCLAIMER The material presented at this meeting represents the opinion of the speakers and not the views of the CSACI. Attendees participating in this medical education program do so with full knowledge that they waive any claim they may have against the CSACI for reliance on any information presented during these educational activities. The CSACI does not guarantee, warrant or endorse any commercial products or services.

Page 5: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

VISIT OUR 2019 SPONSORS AND EXHIBITORS The CSACI meeting has proven to be a great opportunity for a collegial interchange of ideas and product information between physicians and our corporate partners. The exhibit area is the exclusive room for meals and breaks. The exhibiting companies and organizations will provide you with the latest information on products and services available to physicians, researchers and allied health professionals in the field of allergy/immunology. For more information on exhibiting companies and organization, please refer to the Annual Meeting app.

PLEASE NOTE THIS MEETING

IS FRAGRANCE FREE

APP QR CODE Sponsored by:

Pediapharm

Want to win a gift card but tired of filling out the exhibitor passport?

The CSACI Trivia Game

…stay tuned for more details.

Page 6: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

CSACI SOCIAL EVENTS

The CSACI will be holding two social events that will provide you with an opportunity to connect with fellow delegates in a more relaxed environment. This includes the opening reception to be held on Friday, October 25 from 1830-1930 where Dr. Harold Kim will present plaques to our corporate partners. On the evening Saturday October 26, the CSACI Executive and Board will be hosting the CSACI dinner. Prizes will be presented for the best posters and awards to pay special homage to our speakers and exemplary CSACI members for their outstanding achievements in the allergy, asthma and immunology field.

Follow the CSACI Annual Meeting on Twitter

While you’re in Montreal use #CSACI19 when you tweet to

participate in onsite conversations & share what you’re learning with

your colleagues

Page 8: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

WEDNESDAY, OCTOBER 23, 2019

1530-1645 ROYAL COLLEGE SPECIALTY COMMITTEE MEETING (closed) Outremont 5 Moderator: Dr. Fanny Silviu-Dan 1645-1745 CHIEF/CHAIRS MEETING Outremont 7 Moderator: Dr. H. Kim 1800-2100 CAAIF BOARD MEETING (closed) Outremont 7 1800-2100 CSACI DINNER & BOARD MEETING (closed) Outremont 5 1830-2000 NREP DINNER & MEETING (closed) Bonaventure 2100-2200 FIT|NREP|CSACI PROGRAM DIRECTORS NETWORKING RECEPTION Ville-Marie

THURSDAY, OCTOBER 24, 2019

0715-0800 FELLOW-IN-TRAINING (FIT) OSCE BREAKFAST & ORIENTATION (CLOSED) Ville-Marie WORKSHOP SESSIONS ONLY FOR FIT’S

0730-0800 TOPIC: OSCE TIPS AND TECHNIQUES Ville-Marie SPEAKER: Dr. Ana Copaescu, Montreal, QC

BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *Objectives:

1) Discuss approach to studying for OSCE examinations 2) List suggested study resources for Royal College examinations – Royal

College Objectives, Exam Review courses, textbooks, websites, ETC. 3) Summarize tips on staying sane while studying for your first and second

Royal College Examinations 0715-0800 OSCE EXAMINERS BREAKFAST & ORIENTATION (CLOSED) Bonaventure 0810-1000 OSCE CONCURRENT SESSIONS - (CLOSED) Montréal 6-7-8 BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*:

*Objectives: 1) Prepare trainees with an opportunity to practice for their Allergy

/Clinical Immunology Fellowship examination 2) Provide feedback to trainees by experienced examiners

Page 9: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

THURSDAY, OCTOBER 24, 2019

1000-1315 FIT WORKSHOP (CLOSED) – WORKSHOP SESSIONS ONLY FOR FIT’S Ville-Marie MODERATORS: Dr. A. Copaescu, Dr. Z. Abdurrahman and Dr. A. Segal

1015-1100 – SPEAKERS: Dr. Emil Nashi, McGill University, Dr. Christine Song, University of Toronto and Dr. Moshe Ben-Shoshan, McGill University TOPIC: DRUG ALLERGY FOR THE COMMUNITY ALLERGIST OBJECTIVES:

1) Describe the variations in practice concerning drug allergy management across Canada.

2) Recognize the challenges and controversies of treating patients with drug allergy in the community.

3) Understand the role and risks of penicillin challenges in the community.

1100-1145 – SPEAKER: Dr. Natacha Tardio, McGill University TOPIC: EOSINOPHILIC DISORDERS OBJECTIVES:

1) Discuss the diagnosis of eosinophilic disorders. 2) Describe the investigations that can be done in the allergy department

for eosinophilic disorders. 3) Summarize the management possibilities for Eosinophilic esophagitis

from the allergist's point of view.

1145-1205 ELECTIONS – and FIT Junior Representative Elections 1205-1220 LUNCH

1220-1310 - SPEAKERS - Dr. Alizadehfar Reza, McGill University, Dre Kathryn Samaan, Université de Montréal and Allison Haynes, Memorial University TOPIC: – IMMUNODEFICIENCY IN THE COMMUNITY – PANEL DISCUSSION

BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *OBJECTIVES:

1) Understand the variations in practice concerning immunodeficiency management across Canada.

2) Relate the controversies and challenges in investigating and treating patients with immunodeficiency in the community.

1310-1315 – SPEAKER – Dr. Harold Kim, Kitchener, ON TOPIC: AACI JOURNAL DISCUSSIONS

Page 10: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

THURSDAY, OCTOBER 24, 2019

REGULAR PROGRAM 0945-1015 REFRESHMENT BREAK 1000-1200 TRAINEE CAREER DEVELOPMENT Saint-Laurent 5 1115-1145 MODERATOR/CHAIR ORIENTATION Outremont 4 1200-1230 LUNCH Saint-Laurent 1-2-3-4 1230-1330 LUNCH SYMPOSIUM Montréal 1-2-3-4-5 1330-1730 IMMUNODEFICIENCY CANADA SYMPOSIUM ON PRIMARY IMMUNODEFICIENCY* Montréal 1-2-3-4-5

*“This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, and approved by Canadian Society of Allergy and Clinical Immunology.”

1500-1530 REFRESHMENT BREAK Saint-Laurent 1-2-3-4 1830-2200 CAAIF GALA – LE WINDSOR BALLROOM

Page 11: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

FRIDAY, OCTOBER 25, 2019

0700-0730 BREAKFAST Saint-Laurent 1-2-3-4 0730-0830 BREAKFAST SYMPOSIUM Montréal 1-2-3-4-5 0845-1025 PLENARY SESSION I – Food Allergy/OIT (Section 3 – Q&As must be responded to

receive credits) Montréal 1-2-3-4-5 MODERATORS: Dr. S. Kapur and Dr. E. Lavine

0845-0910 – SPEAKER: Dr. Edmond Chan, Vancouver, BC TOPIC: EPIT vs OIT vs Avoidance: Where are we in 2019? BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *Objectives:

1) Compare the risks of each approach for patients 2) Discuss the potential benefits of each approach 3) Summarize the “State-Of-The Art’ of each approach

0910-0935 – Speaker: Dr. Dave Stukus, Columbus, OH TOPIC: FOOD CHALLENGES IN INFANTS AND TODDLERS OBJECTIVES:

1) Choose the right individuals for food challenges and what to challenge

2) Demonstrate the process of oral food challenges including obtaining informed consent

3) Properly judge the risk/benefit ratio of oral challenges 0935-1000 – Speaker: Dr. Philippe Bégin, Montreal, QC TOPIC: USING BIOLOGIC AGENTS IN THE SETTING OF OIT OBJECTIVES:

1) Describe the biologic agents that could prove helpful for OIT

2) Appraise the data supporting the use of biologic agents for OIT

3) Estimate the potential level of protection biologic agents provide for OIT 1000-1025 – Discussion Period

1025-1050 NUTRITION & NETWORKING BREAK Saint-Laurent 1-2-3-4 1055-1200 CSACI & CAAIF AGM’S (CSACI members only) Montréal 1-2-3-4-5 1215-1245 LUNCH Saint-Laurent 1-2-3-4

Page 12: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

FRIDAY, OCTOBER 25, 2019

1245-1345 PRO-CON DEBATE*:

*This debate was co-developed with Pfizer Canada and was planned to achieve scientific integrity, objectivity and balance.

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by Canadian Society of Allergy and Clinical Immunology)

Montréal 1-2-3-4-5 A Recent UK Inquest Suggested There Are Design Flaws in Today’s Adrenaline Auto-Injectors (AAI’S). Are Today’s AAI’S Flawed? MODERATORS: Dr. P. Bégin and Dr. M. Ben-Shoshan

Con: Dr. Julia Upton, Toronto, ON Pro: Dr. Harold Kim, Kitchener-Waterloo, ON BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *OBJECTIVES:

1. Describe recent controversies surrounding AAI’s 2. Specify the differences between different AAI’s 3. Discuss needle length and other AAI issue with patients (CANMeds role: communicator).

1400-1440 KEYNOTE PRESENTATION Montréal 1-2-3-4-5 SPEAKER: Dr. Dave Stukus, Columbus, OH

TOPIC: COMBATTING DOCTOR GOOGLE MODERATORS: Dr. H. Kim and Dr. A. Ellis

BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *OBJECTIVES:

1) Identify the sources of misinformation available to our patients 2) Discuss medical myths and misinformation with our patients 3) Explain the potentially beneficial role of Social Media in Medical practice

1440-1510 NUTRITION & NETWORKING BREAK Saint-Laurent 1-2-3-4

Page 13: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

FRIDAY, OCTOBER 25, 2019

1510-1555 PLENARY SESSION II - CONCURRENT WORKSHOPS (PLEASE SELECT ONE WORKSHOP)

INTERDISCIPLINARY WORKSHOPS MODERATORS: Dr. L. Connors and Dr. T. Vander Leek

Saint-Laurent 5 W01a. Dilemmas in Rhinosinusitis Saint-Laurent 7 W02a. The True Role of Food in Eosinophilic Esophagitis: Diagnosis and

Management

IMMUNOLOGY & BASIC SCIENCE WORKSHOP MODERATORS: DR. K. Hildebrand and Dr. H. Vliagoftis

Saint-Laurent 6 W03a. Challenges in Diagnosis of Immunodeficiency Saint-Laurent 8 W04a. Dilemmas in Genetic Assessment of Immunodeficiency Patients

1605-1650 PLENARY SESSION II - CONCURRENT WORKSHOPS (PLEASE SELECT ONE WORKSHOP) Saint-Laurent 5 W01b. Dilemmas in Rhinosinusitis Saint-Laurent 7 W02b. The True Role of Food in Eosinophilic Esophagitis: Diagnosis and

Management Saint-Laurent 6 W03b. Challenges in Diagnosis of Immunodeficiency Saint-Laurent 8 W04b. Dilemmas in Genetic Assessment of Immunodeficiency Patients

W01: DILEMMAS IN RHINOSINUSITIS SPEAKER: Dr. Anne Ellis, Kingston, ON

SPEAKER: Dr. Martin Desrosiers, Montreal, QC OBJECTIVES:

1) Organize data to formulate the correct diagnosis in AR/CRS 2) Integrate new pathophysiologic knowledge of CRS into treatment plans

3) Differentiate the roles of medical and surgical management for CRS W02: THE TRUE ROLE OF FOOD IN EOSINOPHILIC ESOPHAGITIS: DIAGNOSIS AND MANAGEMENT SPEAKER: Dr. Edmond Chan, Vancouver, BC

SPEAKER: Dr. Carina Venter, Denver, CO OBJECTIVES:

1) Demonstrate knowledge of the role of food avoidance in EoE

2) Relate the newest knowledge of evidence-based diagnosis and treatment of EoE

3) Integrate the role of the dietitian in the management of EoE (CANMeds role: collaborator)

Page 14: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

FRIDAY, OCTOBER 25, 2019

W03: CHALLENGES IN DIAGNOSIS OF IMMUNODEFICIENCY SPEAKER: Dr. Eyal Grunebaum, Toronto, ON SPEAKER: Dr. Reza Alizadehfar, Montreal, QC OBJECTIVES:

1) Describe patterns in ID cases to aid in diagnosis

2) Relate the key immunologic pathways that help make diagnoses

3) Create a diagnostic template for investigating future patients

W04: DILEMMAS IN GENETIC ASSESSMENT OF IMMUNODEFICIENCY PATIENTS SPEAKER: Dr. Donald Vinh, Montreal, QC SPEAKER: Dr. Bruce Mazer, Montreal, QC

OBJECTIVES: 1) Discuss controversial questions in the assessment of immunodeficiency within families

2) Explain the pathologic pathways that are genetically determined

3) Review future cases where the causes are genetically determined

1700-1730 ROYAL COLLEGE UPDATE: COMPETENCE BY DESIGN: THE BIGGEST CHANGE TO Saint Laurent 5-6 MEDICAL EDUCATION IN 100 YEARS! SPEAKER: Dr. Adelle Atkinson, Toronto, ON

BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *OBJECTIVES:

1.Explain to a colleague what CBME/CBD is and the rationale for its use in medical training 2.Describe the CBME/CBD approach to medical training 3.Understand what the change to CBME/CBD means for you as a teacher in

Allergy and Clinical Immunology.

1730-1830 FIT BOWL Montréal 1-2-3-4-5 CHAIR: Dr. A. Ellis - MODERATORS: Drs. C. Frankish and W. Moote

BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *OBJECTIVE: Summarize allergy and immunology in a team-based environment.

1830-1930 OPENING RECEPTION WITH EXHIBITORS Saint-Laurent 1-2-3-4

Page 15: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

SATURDAY, OCTOBER 26, 2019

0630-0710 YOGA SESSION Outremont 1

0700-0730 BREAKFAST Saint-Laurent 1-2-3-4 0730-0830 BREAKFAST SYMPOSIUM Montréal 1-2-3-4-5

0730-1235 CONCURRENT - ALLIED HEALTH HALF DAY SYMPOSIUM Salon Bonaventure MODERATORS: Dr. L. Soller and Ms. L. Warner

IT TAKES A VILLAGE: INTERPROFESSIONAL COLLABORATION IN PEDIATRIC ALLERGY CARE BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *OBJECTIVES:

1) Describe the role of allied health professionals in the care of a patient with allergies, from the perspective of a nurse, an asthma educator, and a dietitian.

2) Use role playing to explore the interplay between different allied health professional groups in the treatment and management of children and adults with allergies.

3) Recognize the importance of having a transdisciplinary team in the context of allergy care, and know how to bring together a team in your clinical setting.

7:30-8:30 Breakfast & Networking 8:30-8:45 Introduction and Objectives of the Symposium: Lianne Soller, Vancouver, BC 8:45-9:05 Session 1: Nursing role in Pediatric Allergy Care: Liane Beaudette, Montréal, QC 9:05-9:25 Session 2: Asthma educator role in Pediatric Allergy Care: Tracy Bouwman, Winnipeg, MB

9:25-9:45 Session 3: Dietitian role in Pediatric Allergy Care: Carina Venter, Denver, CO 9:45-9:55 Stretch your legs! 9:55-11:05 Session 4: Small group role playing: Speaker: Linda Warner, Vancouver, BC 11:05-11:35 Discussion & Wrap Up: Lianne Soller 11:35-12:35 AH Section Meeting (Optional)

Page 16: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

SATURDAY, OCTOBER 26, 2019

0845-1025 PLENARY SESSION III – UPDATE ON BIOLOGICS AGENTS Montréal 1-2-3-4-5 MODERATORS: Dr. C. McCusker and Dr. L. Murguia-Favela

0845-0910: SPEAKER: Dr. Thomas Eiwegger, Toronto, ON TOPIC: SIDE EFFECTS OF BIOLOGIC AGENTS BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *OBJECTIVES:

1) Identify the side effects of the biologic agents Allergist/Immunologists typically use

2) Relate the extent of allergic reactions to and the immunologic consequences of biologic agents from other specialties (CANMeds role: Collaborator)

3) Propose plans of action to help those suffering adverse reactions 0910-0935: SPEAKER: Dr. Marcus Shaker, Lebanon, NH TOPIC: AUTO-INFLAMMATORY SYNDROMES—CAUSES AND TREATMENTS OBJECTIVES:

1) Outline the inflammatory pathways that become anti-inflammatory

2) Evaluate patients who may have auto-inflammatory syndromes

3) Choose management strategies for patients with auto-inflammatory syndromes

0935-1000: SPEAKER: Dr. Michael Wechsler, Denver, CO TOPIC: FUTURE ROLES FOR BIOLOGIC AGENTS BEYOND ASTHMA AND ATOPIC DERMATITIS OBJECTIVES:

1) Differentiate between the present-day on-label use of biologic agents for allergic/respiratory disease and those that are off-label

2) List the disease processes now under active investigation for treatment (eg EoE, nasal polyposis and Churg-Strauss syndrome)

3) Evaluate the present state of knowledge for the use of biologic agents for these indications

1000-1025 DISCUSSION PERIOD

Page 17: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

SATURDAY, OCTOBER 26, 2019

1025-1045 NUTRITION & NETWORKING BREAK Saint-Laurent 1-2-3-4 1050-1200 INTEREST SECTION MEETINGS: (See meeting app for all details)

• IMMUNOLOGY: MODERATOR: Dr. L. Murguia-Favela – St-Laurent 7

• RHITINIS: MODERATOR: Dr. J. Quirt – Westmount 6

• ANAPHYLAXIS: MODERATOR: Dr. J. Upton – St-Laurent 5

• ASTHMA: MODERATOR: Dr. A. O’Keefe – St-Laurent 8

• PEDIATRICS: MODERATOR: Dr. E. Lavine – St-Laurent 6

• ALLIED HEALTH: MODERATOR: Dr. L. Soller – Salon Bonaventure 1200-1235 INDUSTRY SUMMIT (CLOSED) Outremont 4 1200-1215 SUMMER STUDENTSHIPS IN ALLERGY AND IMMUNOLOGY RESEARCH Montréal 1-2-3-4-5 PRESENTATIONS

MODERATORS: Dr. V. Cook and Dr. BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *OBJECTIVES: Describe recent research findings in the field of Allergy Immunology

1200-1203 Christiane Blais The effect of deep inhalation on mannitol responsiveness

1203-1206 Tatjana Brauer-Chapin Investigation of B cell function and differentiation in vitro

1206-1209 Sarah Almas Intracellular cytokine release from eosinophils

1209-1212 Anna Branch Clinical Predictors of Primary Immune Deficiencies: a systematic review and initial results from a patient cohort

1212-1215 Paul Spill Investigating the Maintenance of Food Allergy in Humans

Page 18: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

SATURDAY, OCTOBER 26, 2019

1215-1246 ABSTRACT ORAL PRESENTATIONS CLINICAL Montréal 1-2-3-4-5 MODERATORS: Dr. H. Vliagoftis, Dr. E. Simons, Dr. S. Jeimy And Dr. C. Biggs

BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *OBJECTIVES: Describe recent research findings in the field of Allergy Immunology

IMMUNOLOGY

1215-1218 Eisha Ahmed Distribution and phenotype of murine regulatory B cells in HDM-driven allergic airway disease

1218-1221 Mahdi Hassan MASTER: MASTtocytosis to study Evolution Registry

1221-1224 Son Tran Expression profiles of primary immunodeficiency associated genes in adult cancers and their incidence and implications in pediatric malignancies

OTHER ALLERGY/IMMUNOLOGY

1225-1228 Luca Delli Colli Diagnosing serum sickness-like reactions using a graded oral challenge

1228-1231 Hailey Hildebrand Dairy quality amongst adolescents with a history of eczema: Results from the SAGE Birth Cohort by Hailey Hildebrand

1231-1234 Melanie Wong Assessing quality of life instruments for patients with nasal polyposis: a systematic review

URTICARIA/ANGIOEDEMA

1234-1237 Bruce Thomas Miles Clinical characteristics and management of inducible chronic urticaria in a pediatric cohort

1237-1240 Hoang Pham Remission of acquired angioedema with C1 esterase deficiency from chronic lymphocytic leukemia achieved with ibrutinib therapy

1240-1243 Peter Stepaniuk Natural history, prognostic factors and burden of disease in chronic urticaria

FOOD ALLERGY/ANAPHYLAXIS

1243-1246 Abeer Hegazi Usability Evaluation of the Canadian Anaphylaxis Emergency Plan: Opportunity for Improvement

Please note remaining Food Allergy/Anaphylaxis Oral presentations will be presented at 1800

1245-1315 LUNCH Saint-Laurent 1-2-3-4 1315-1415 LUNCH SYMPOSIUM Montréal 1-2-3-4-5

Page 19: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

SATURDAY, OCTOBER 26, 2019

1425-1530 POSTER VIEWING AND JUDGING SESSION Montréal 6-7-8 MODERATORS: Dr. H. Vliagoftis, Dr. E. Simons, Dr. S. Jeimy And Dr. C. Biggs 1530-1700 FREE TIME 1545-1645 JOURNAL MEETING (closed) Westmount 1 Moderator: Dr. R. Warrington, Winnipeg, MB 1800-1900 CONCURRENT SESSIONS: St-Laurent 5-6 MODERATORS: Dr. H. Vliagoftis, Dr. E. Simons, Dr. S. Jeimy And Dr. C. Biggs

CONCURRENT ABSTRACT ORAL PRESENTATIONS ALLIED HEALTH, FOOD ALLERGY/ANAPHYLAXIS

Food Allergy/Anaphylaxis 1800-1803 Khaldon Abbas Anaphylaxis in Oral allergy Syndrome: A Case Series

1803-1806 Sabrina Bartolucci Exercise-associated anaphylaxis co-factors and epinephrine administration

1806-1809 Casey Cohen Evaluating new processing methods and their effects on peanut allergenicity

1809-1812 Élise Dufresne Quality-adjusted life-year gain with oral immunotherapy: preliminary results from a real-life cohort

1812-1815 Sofianne Gabrielli First anaphylactic reactions among children from the Cross-Canada Anaphylaxis REgistry (C-CARE)

1815-1818 Judy Gaffar Diagnosis of ibuprofen allergy through oral challenge

1818-1821 Hélène Leroux Efficiency of peanut suspension with simple syrup compared to individual pre-weighted flour doses for oral immunotherapy

1821-1824 Melanie Leung Increased risk of anaphylaxis during Halloween and Easter in Canadian children

1824-1827 Keely Loewen School principals’ reports of epinephrine auto-injector accessibility and administration in Manitoba schools

1827-1830 Laura Miles Pre-hospital management of anaphylaxis in rural Quebec

1830-1833 Salma Rehimini Specific IgE antibody levels during and after food-induced anaphylaxis

1833-1837 Eunice Tunggal Evaluation of a Canadian oral immunotherapy community programme

1837-1840 Dennis Wong Anaphylaxis to Hemp Seed Ingestion: A Case Series

1840-1843 Yi Zhang Milk immunotherapy induces casein-specific, CD137+ FOXP3+ regulatory T cells during oral-induced tolerance among children.

1843-1846 Wei Zhao Serological analysis of milk oral immunotherapy participants

1846-1849 Shun Chi Ryan Lo A survey-based evaluation of cannabis hypersensitivity in Vancouver allergy practices following legalization of recreational marijuana

Allied Health

1849-1851 Alexander Shusterman Mast Cell Activation Syndrome (MCAS): Symptom prevalence and characteristic of patients with this presumed diagnosis

Page 20: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

SATURDAY, OCTOBER 26, 2019

1800-1900 CONCURRENT SESSIONS: St-Laurent 7-8 MODERATORS: Dr. H. Vliagoftis, Dr. E. Simons, Dr. S. Jeimy And Dr. C. Biggs

CONCURRENT ABSTRACT ORAL PRESENTATIONS CASE REPORTS

CASE REPORTS

1800-1803 Babak Aberumand An uncommon case of insulin allergy

1803-1806 Leila A. Alenazy Anaphylaxis to cricket powder in a patient with shellfish allergy

1806-1809 Zeinah AlHalees A Non-Pigmenting Fixed Drug Eruption (NPFDE) to Cephalexin in a Child

1812-1815 Ashwag Alsaidalani Castleman Disease

1815-1818 Angeliki Barlas Anaphylaxis caused by trace exposure to angiotensin II blocker in a healthcare worker: A case report

1818-1821 Ana Maria Bosonea Failure of immunotherapy as treatment of Post-Orgasmic Illness Syndrome (POIS)

1821-1824 Robyn Cochrane Fones Anaphylaxis to cow's milk after pregnancy

1824-1827 Hannah Laure Elfassy A compound heterozygous Factor I mutation family and invasive pneumococcal infection.

1827-1830 Kristiina Frechette It’s not just rice! Food protein-induced enterocolitis to grains: single vs multiple and the benefits of structured medical challenges

1830-1833 Kelsey Hinther An atypical presentation of ceftriaxone and vancomycin hypersensitivity reaction: A case report

1833-1836 Sarah Lohrenz ACE inhibitor induced angioedema treated with C1 inhibitor concentrate in the emergency department

1836-1839 Tarin Moni Is it allergy? Photodermatitis mimicking the effects of allergic contact dermatitis

1839-1842 Pasquale Mulé Anaphylaxis to goat/sheep milk in a 4-year-old boy tolerant to cow milk

1842-1845 Kara Robertson Food-dependent exercise-induced anaphylaxis to almond in a 22-year-old male athlete

1845-1848 Juan Camilo Ruiz Cashew food allergy causing anaphylaxis and pancreatitis in a young Japanese man

1848-1851 Saghar Sadeghi A novel BTK gene mutation, T354I, in a patient with X-linked agammaglobulinemia

1851-1854 Wardha Wardha Playing with Fire: The risks associated with intradermal cephalosporin testing.

1854-1857 Andrew Wong-Pack Anaphylaxis to cilantro during an oral challenge

1900-1930 CSACI RECEPTION Ville Marie 1930-2200 CSACI DINNER AND AWARDS Montréal 1-2-3-4-5

Page 21: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

SUNDAY, OCTOBER 27, 2019

0700-0730 BREAKFAST Saint-Laurent 1-2-3-4 0730-0825 BREAKFAST SYMPOSIUM Montréal 1-2-3-4-5 0840-1020 PLENARY SESSIONS IV – Challenges in Anaphylaxis (Section 3 – Q&As must be

Responded to receive credits) Montréal 1-2-3-4-5 MODERATORS: Dr. M. Picard and Dr. J. Upton

0840-0905: SPEAKER: Dr. Moshe Ben-Shoshan, Montreal, QC TOPIC: Gaps in Anaphylaxis Management: Lessons learned from the C-CARE Database BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *OBJECTIVES: 1) Outline the gaps in the treatment of anaphylactic reactions from onset to the Emergency Department 2) Contrast evidence-based management with what actually occurs 3) Discuss strategies to improve community

0905-0930: SPEAKER: Dr. Franziska Rueff, Munich, Germany TOPIC: Drugs and Other Co-Factors in Anaphylaxis OBJECTIVES:

1) List the co-factors associated with worsening of anaphylaxis

2) Relate the biologic basis for these worsenings

3) Compare the severity of reactions between ACE inhibitors and beta-blockers

0930-0955: SPEAKER: Dr. Mariana Castells, Boston, MA TOPIC: Idiopathic Anaphylaxis OBJECTIVES:

1) Differentiate between MCAS and Idiopathic Anaphylaxis

2) Outline the workup of these patients including serum tryptase levels

3) Relate treatment strategies for MCAS/Idiopathic anaphylaxis

0955-1020 DISCUSSION PERIOD 1020-1045 NUTRITION BREAK Saint-Laurent 1-2-3-4

Page 22: th - CSACI...Dr. Hari Vliagoftis, CSACI Board and Abstract Co-Chair Dr. Wade Watson, 2019 Program Committee, CPD Com. Ms. Louise Tremblay, Executive Director Ms. Alexi …

SUNDAY, OCTOBER 27, 2019

1045-1220 PLENARY SESSION V - LITERATURE REVIEW Montréal 1-2-3-4-5 MODERATORS: Dr. J. Quirt and Dr. A. O’Keefe 1045-1105 - BASIC SCIENCE: Dr. Jean Marshall, Halifax, NS 1105-1125 - PEDIATRICS: Dr. Wade Watson, Halifax, NS 1125-1145 - ADULT: Dr. Paul Keith, Hamilton, ON

BY THE END OF THESE SESSIONS PARTICIPANTS WILL BE ABLE TO*: *OBJECTIVES:

1) Cite the conclusions of the best papers of this year

2) Critique the newest information with respect to previous knowledge

3) Select which papers could benefit from further review 1145-1200 DISCUSSION PERIOD 1205 CLOSING REMARKS BY THE CSACI PRESIDENT, DR. HAROLD KIM

1200-1245 LUNCH WILL BE SERVED IN THE REGISTRATION LOBBY